News

CPR-22 TABLET PRESS

Exploring the Benefits of the CPR-22 Tablet Press Machine

If you work in the pharmaceutical or nutraceutical industry, you know how critical precision and efficiency are in tablet production. The CPR-22 Tablet Press Machine by Dott. Bonapace is a standout tool designed to meet these needs.

Whether you are producing single-layer or double-layer tablets, the CPR-22 offers a versatile and reliable solution for both R&D and small-scale production.

Key Features and Advantages
  1. Dual-Layer Capability
    The CPR-22 provides the flexibility to upgrade from a single-layer to a double-layer configuration without requiring the purchase of an additional machine. This innovative feature sets it apart from many industry-leading brands, where such an upgrade typically necessitates investing in a separate unit. This flexibility makes it ideal for manufacturers looking to produce complex formulations, such as tablets with immediate-release and sustained-release layers.
  2. Motorized dosing cams
    The CPR-22 is equipped with motorized dosing cams, eliminating the need for multiple sets to accommodate different dosages. This advanced functionality delivers substantial cost savings for users manufacturing products with significantly varying dimensions.
  3. Compact Design, Powerful Performance
    With its rotary design, the CPR-22 provides high precision and consistent performance while maintaining a compact footprint. This makes it an excellent fit for laboratories and facilities where space is at a premium.
  4. User-Friendly Operation
    The machine is designed with ease of use in mind, incorporating intuitive controls and efficient mechanisms for tablet compression. Whether you’re running trials or small production batches, operators can quickly adapt to its workflow.
  5. High-Quality Output
    The precision engineering ensures consistent tablet weight, hardness, and quality, reducing waste and ensuring compliance with industry standards.
Why the CPR-22 Matters

In today’s competitive market, innovation and flexibility are essential.

The CPR-22 empowers companies to experiment with new formulations and expand product lines without the need for large-scale equipment investments.

It’s particularly useful for:

  • Pharmaceutical companies conducting R&D.
  • Nutraceutical producers developing multi-functional supplements.
  • Herbal medicine manufacturers looking for reliable small-scale solutions.
Conclusion

The CPR-22 isn’t just a machine – it’s a tool for growth and innovation. Its ability to adapt to various production needs and ensure high-quality output makes it an indispensable asset for modern laboratories and small production lines.